Impact of Baseline and Week 2 and Week 4 Posttransplant CMV Cell-Mediated Immunity on Risk of CMV Infections and Mortality in Recipients of Allogeneic Hematopoietic Cell Transplant.
Ella J Ariza-HerediaDrew J WinstonScott D RowleyKathleen MullanePranatharthi ChandrasekarParameswaran HariRobin K AveryKarl S PeggsDeepali KumarRajneesh NathPer LjungmanSherif B MossadLynn El HaddadDimpy P ShahYing JiangFareed KhawajaSanjeet DadwalTed BlanchardRoy F ChemalyPublished in: Open forum infectious diseases (2023)
A decrease in CMV-specific T-cell responses during the first month after transplant may predict CS-CMVi and is associated with all-cause mortality in recipients of alloHCT.